TABLE 3.
Main discriminant auxanographic features based on the study of 17 reference strains and 30 clinical isolates
| Strain testeda | No. of strains tested | Substrateb
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sucrose | l(−)-Arabitol | d(−)-Tartrate | Ben-zoate | 5-Keto-d-gluconate | Genti-sate | Putre-scine | dl-Lactate | 5-Amino-valerate | Trypt-amine | Histamine | ||
| RFLP group 2 | ||||||||||||
| B. multivoransT | 1 | − | + | − | + | − | + | + | − | + | + | + |
| Clinical strains | 16 | − | 15/16 | 1/16 | 15/16 | 4/16 | + | 10/16 | 2/16 | 13/16 | 11/16 | 12/16 |
| RFLP group 1 | ||||||||||||
| Reference strains of B. cepacia gv I | 3 | + | + | − | + | + | + | + | + | + | 2/3 | + |
| Reference strain of B. cepacia gv III | 1 | + | + | − | − | + | + | − | + | + | + | − |
| Clinical strains | 8 | + | + | − | 5/8 | + | 5/8 | 4/8 | 7/8 | 5/8 | 3/8 | 1/8 |
| RFLP group 3 | ||||||||||||
| Reference strain of B. cepacia gv IV | 1 | − | + | − | + | + | + | + | + | + | − | + |
| B. pyrrociniaT | 1 | + | + | − | + | + | − | + | + | + | + | + |
| Clinical strain | 1 | − | + | − | + | + | + | + | + | + | + | + |
| RFLP group 4 | ||||||||||||
| B. vietnamiensisT | 1 | + | − | − | + | − | − | + | + | + | − | + |
| Clinical strain | 1 | − | + | − | + | − | + | − | − | − | − | − |
| RFLP group 5 | ||||||||||||
| B. gladioli pathovar gladioliT | 1 | − | − | + | + | + | − | − | + | − | − | − |
| B. cocovenenansT | 1 | − | − | + | + | + | − | − | + | − | − | − |
| Clinical strain | 1 | − | − | + | − | − | − | − | + | − | − | − |
| RFLP group 6 | ||||||||||||
| B. gladioli pathovar alliicolaT | 1 | − | − | + | + | + | − | − | + | − | − | − |
| Clinical strain | 1 | − | − | − | − | + | − | − | + | − | − | − |
| RFLP group 15, clinical strain | 1 | + | + | − | + | + | + | + | + | − | − | − |
| RFLP group 16, clinical strain | 1 | + | − | + | − | − | + | − | + | + | − | − |
| RFLP group 7, B. plantariiT | 1 | − | − | + | − | − | − | − | + | − | − | − |
| RFLP group 8, B. caryophilliT | 1 | + | − | − | − | + | − | − | + | − | − | − |
| RFLP group 9, B. andropogonisT | 1 | − | − | − | − | − | − | − | + | − | − | − |
| RFLP group 10, B. glumaeT | 1 | − | − | − | + | − | − | − | + | − | + | − |
| RFLP group 12, R. pickettiiT | 1 | − | − | − | − | − | − | − | + | − | − | + |
| RFLP group 13, S. maltophiliaT | 1 | + | − | − | − | − | − | − | + | − | − | − |
a
gv, genomovar; T, type strain. The groups are defined on the basis of the RFLP profiles obtained with AluI, CfoI, DdeI, and MspI.
b
+, all strains tested positive; −, all strains tested negative. Ratios give the number of positive strains over the total number of strains tested.